Frank Aquila Discusses Grifols Purchase of Talecris

Loading player, please wait...
  • Info

  • Comments

June 7 (Bloomberg) -- Frank Aquila, a partner at Sullivan & Cromwell LLP, talks with Bloomberg's Lori Rothman about Grifols SA's agreement to buy Talecris Biotherapeutics Holdings Corp. for about $3 billion in cash and stock to expand its share to almost a third of the U.S. market. Barcelona-based Grifols is Europe’s largest maker of blood-plasma products. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change